Biesecker, L. G. & Spinner, N. B. A genomic view of mosaicism and human disease. Nat. Rev. Genet. 14, 307–320 (2013).
Lupski, J. R. Genome mosaicism–one human, multiple genomes. Science 341, 358–359 (2013).
Acuna-Hidalgo, R. et al. Post-zygotic point mutations are an underrecognized source of de novo genomic variation. Am. J. Hum. Genet. 97, 67–74 (2015).
Campbell, I. M. et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am. J. Hum. Genet. 95, 173–182 (2014).
Halvorsen, M. et al. Mosaic mutations in early-onset genetic diseases. Genet. Med. 18, 746–749 (2016).
Myers, C. T. et al. Parental mosaicism in “de novo” epileptic encephalopathies. N. Engl. J. Med. 378, 1646–1648 (2018).
Campbell, I. M. et al. Parent of origin, mosaicism, and recurrence risk: probabilistic modeling explains the broken symmetry of transmission genetics. Am. J. Hum. Genet. 95, 345–359 (2014).
Breuss, M. et al. Quantification of autism recurrence risk by direct assessment of paternal sperm mosaicism. BioRxiv. https://doi.org/10.1101/208165 (2017)
Jonsson, H. et al. Recurrence of de novo mutations in families. BioRxiv. https://doi.org/10.1101/221259 (2017)
Rahbari, R. et al. Timing, rates and spectra of human germline mutation. Nat. Genet. 48, 126–133 (2016).
Poduri, A., Evrony, G. D., Cai, X. & Walsh, C. A. Somatic mutation, genomic variation, and neurological disease. Science 341, 1237758 (2013).
Nathan, N., Keppler-Noreuil, K. M., Biesecker, L. G., Moss, J. & Darling, T. N. Mosaic disorders of the pi3k/pten/akt/tsc/mtorc1 signaling pathway. Dermatol Clin. 35, 51–60 (2017).
Ansari, M. et al. Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism. J. Med. Genet. 51, 659–668 (2014).
Goriely, A. et al. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in “paternal age-effect” syndromes. Am. J. Med. Genet. A 152A, 2067–2073 (2010).
Xin, B. et al. Novel DNMT3A germline mutations are associated with inherited Tatton-Brown-Rahman syndrome. Clin. Genet. 91, 623–628 (2017).
Stosser, M. B. et al. High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders. Genet. Med. https://doi.org/10.1038/gim.2017.114 (2017)
King, D. A. et al. Detection of structural mosaicism from targeted and whole-genome sequencing data. Genome Res. 27, 1704–1714 (2017).
King, D. A. et al. Mosaic structural variation in children with developmental disorders. Hum. Mol. Genet. 24, 2733–2745 (2015).
Papavassiliou, P., Charalsawadi, C., Rafferty, K. & Jackson-Cook, C. Mosaicism for trisomy 21: a review. Am. J. Med. Genet. A 167A, 26–39 (2015).
Delhanty, J. D. A. Inherited aneuploidy: germline mosaicism. Cytogenet Genome Res 133, 136–140 (2011).
Conlin, L. K. et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum. Mol. Genet. 19, 1263–1275 (2010).
Krupp, D. R. et al. Exonic mosaic mutations contribute risk for autism spectrum disorder. Am. J. Hum. Genet. 101, 369–390 (2017).
Lim, E. T. et al. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder. Nat. Neurosci. 20, 1217–1224 (2017).
Huisman, S. A., Redeker, E. J. W., Maas, S. M., Mannens, M. M. & Hennekam, R. C. M. High rate of mosaicism in individuals with Cornelia de Lange syndrome. J. Med. Genet. 50, 339–344 (2013).
Qin, L. et al. Detection and quantification of mosaic mutations in disease genes by next-generation sequencing. J. Mol. Diagn. 18, 446–453 (2016).
Gajecka, M. Unrevealed mosaicism in the next-generation sequencing era. Mol. Genet. Genom. 291, 513–530 (2016).
Metzker, M. L. Sequencing technologies—the next generation. Nat. Rev. Genet. 11, 31–46 (2010).
Rios, J. J. & Delgado, M. R. Using whole-exome sequencing to identify variants inherited from mosaic parents. Eur. J. Hum. Genet. 23, 547–550 (2015).
Contini, E. et al. A systematic assessment of accuracy in detecting somatic mosaic variants by deep amplicon sequencing: application to NF2 gene. PLoS ONE 10, e0129099 (2015).
de Lange, I. M. et al. Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes. Epilepsia 59, 690–703 (2018).
Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 542, 433–438 (2017).
Wright, C. F. et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet 385, 1305–1314 (2015).
Wright, C. F. et al. Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders. Genet. Med. 20, 1216–1223 (2018).
Firth, H. V. & Wright, C. F., DDD Study. The deciphering developmental disorders (DDD) study. Dev. Med. Child Neurol. 53, 702–703 (2011).
Marini, C., Mei, D., Helen Cross, J. & Guerrini, R. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia 47, 1737–1740 (2006).
Nakayama, T. et al. Somatic mosaic deletions involving SCN1A cause Dravet syndrome. Am. J. Med. Genet. A 176, 657–662 (2018).
Meisler, M. H. et al. SCN8A encephalopathy: research progress and prospects. Epilepsia 57, 1027–1035 (2016).
Wall, J. D. et al. Estimating genotype error rates from high-coverage next-generation sequence data. Genome Res. 24, 1734–1739 (2014).
Jónsson, H. et al. Parental influence on human germline de novo mutations in 1,548 trios from Iceland. Nature 549, 519–522 (2017).
Snape, K. et al. Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. Nat. Genet. 43, 527–529 (2011).
Hochstenbach, R. et al. Monosomy 20 mosaicism revealed by extensive karyotyping in blood and skin cells: case report and review of the literature. Cytogenet Genome Res 144, 155–162 (2014).
Choufani, S. et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat. Commun. 6, 10207 (2015).
Brzezinski, J. et al. Wilms tumour in Beckwith-Wiedemann Syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines. Eur. J. Hum. Genet. 25, 1031–1039 (2017).
Butcher, D. T. et al. CHARGE and Kabuki Syndromes: gene-specific dna methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions. Am. J. Hum. Genet. 100, 773–788 (2017).
Jamuar, S. S. et al. Somatic mutations in cerebral cortical malformations. N. Engl. J. Med. 371, 733–743 (2014).
Hiatt, J. B., Pritchard, C. C., Salipante, S. J., O’Roak, B. J. & Shendure, J. Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res. 23, 843–854 (2013).
Kennedy, S. R. et al. Detecting ultralow-frequency mutations by duplex sequencing. Nat. Protoc. 9, 2586–2606 (2014).
Yang, X. et al. Genomic mosaicism in paternal sperm and multiple parental tissues in a Dravet syndrome cohort. Sci. Rep. 7, 15677 (2017).
Bragin, E. et al. DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Res. 42, D993–D1000 (2014).
Köhler, S. et al. The human phenotype ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res. 42, D966–D974 (2014).
Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature 519, 223–228 (2015).
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Ramu, A. et al. DeNovoGear: de novo indel and point mutation discovery and phasing. Nat. Methods 10, 985–987 (2013).
1000 Genomes Project Consortium. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
UK10K Consortium. et al. The UK10K project identifies rare variants in health and disease. Nature 526, 82–90 (2015).
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).
Samocha, K. E. et al. A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 46, 944–950 (2014).
Thorvaldsdóttir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178–192 (2013).